Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

iView Therapeutics Inc
Profile last edited on: 7/16/2023      CAGE: 7HLG3      UEI: YMCPKUN173R3

Business Identifier: Novel formulations to overcome drug delivery issues
Year Founded
2015
First Award
2016
Latest Award
2019
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

5 Cedarbrook Drive Suite 2
Cranbury, NJ 08512
   (609) 773-8580
   N/A
   www.iviewtherapeutics.com
Location: Single
Congr. District: 12
County: Middlesx

Public Profile

IVIEW Therapeutics is a specialty pharmaceutical company focused on topical drug and medical device development with specific emphasis on the therapeutic areas of ophthalmology, dermatology, Otolaryngology and Gynecology. Previously located in the Pennsylvania Biotechnology Center of Bucks County (Doylestown, PA) the firm has now relocated to Cranbury NJ. The firm has also set up a joint-venture corporation in Wuhu, China for development efforts in the China market.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$578,094
Phase II Dollars
$325,000
Total Awarded
$903,094

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2019 2 NIH $579,745
Project Title: In-Situ Gel of Povidone Iodine/Budesonide as Sustained Nasal Drug Delivery for the Treatment of Chronic Rhinosinusitis
2017 1 NIH $323,349
Project Title: Novel Extended Release Povidone Iodine Ophthalmic Drop for Viral Conjunctivitis

Key People / Management

  Bo Liang -- Co-founder, President & Director

  John J Baldwin -- Co-Founder and Director

  Kathleen Czupich

  Xiang Jin

  Yong Lu

  Hany Michail -- Chief Medical Officer

  Gang Wei -- Ocular Drug Delivery Formulation Specialist

Company News

There are no news available.